Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $874.64 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sun Pharmaceutical Industries Inc. | $220.90 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $127.53 | 15 | $0 (2019) |
| ABBVIE INC. | $91.51 | 4 | $0 (2024) |
| Shire North American Group Inc | $70.29 | 4 | $0 (2018) |
| Alcon Vision LLC | $67.16 | 1 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $46.17 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $43.08 | 2 | $0 (2024) |
| Thea Pharma Inc. | $42.40 | 2 | $0 (2024) |
| Oyster Point Pharma, Inc. | $34.89 | 1 | $0 (2023) |
| Rayner Intraocular Lenses Limited | $29.12 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $216.27 | 10 | ABBVIE INC. ($69.76) |
| 2023 | $177.97 | 5 | Alcon Vision LLC ($67.16) |
| 2022 | $29.12 | 2 | Rayner Intraocular Lenses Limited ($29.12) |
| 2021 | $124.94 | 1 | SUN PHARMACEUTICAL INDUSTRIES INC. ($124.94) |
| 2020 | $63.37 | 3 | Sun Pharmaceutical Industries Inc. ($41.93) |
| 2019 | $83.65 | 5 | Sun Pharmaceutical Industries Inc. ($22.07) |
| 2018 | $131.50 | 15 | Novartis Pharmaceuticals Corporation ($109.03) |
| 2017 | $47.82 | 3 | Shire North American Group Inc ($47.82) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: EYE CARE | ||||||
| 12/11/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/16/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: OPTOMETRY | ||||||
| 09/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: EYE CARE | ||||||
| 08/29/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Ophthalmology | ||||||
| 03/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: EYE CARE | ||||||
| 09/13/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $34.89 | General |
| Category: DRY EYE | ||||||
| 08/16/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $31.96 | General |
| Category: Ophthalmology | ||||||
| 04/29/2023 | Thea Pharma Inc. | — | Food and Beverage | In-kind items and services | $22.21 | General |
| 04/28/2023 | AbbVie Inc. | LUMIGAN (Drug), VUITY, ALPHAGAN P | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: EYE CARE | ||||||
| 02/23/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $67.16 | General |
| Category: Ophthalmology | ||||||
| 06/29/2022 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $12.57 | General |
| Category: Ophthalmology | ||||||
| 05/12/2022 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $16.55 | General |
| Category: Ophthalmology | ||||||
| 06/17/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $124.94 | General |
| Category: Ophthalmology | ||||||
| 10/07/2020 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: OCULAR | ||||||
| 06/22/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Ophthalmology | ||||||
| 01/16/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: Ophthalmology | ||||||
| 10/24/2019 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $22.07 | General |
| Category: Ophthalmology | ||||||
| 10/17/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/11/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $15.13 | General |
| Category: Ophthalmology | ||||||
| 05/28/2019 | Eyevance Pharmaceuticals LLC | Flarex (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,566 | 1,837 | $280,192 | $131,760 |
| 2022 | 13 | 1,712 | 1,955 | $304,922 | $149,443 |
| 2021 | 12 | 1,704 | 1,939 | $391,565 | $156,363 |
| 2020 | 13 | 1,737 | 1,961 | $424,845 | $151,619 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 443 | 458 | $87,865 | $39,102 | 44.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 43 | 60 | $54,682 | $26,382 | 48.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 211 | 377 | $51,732 | $26,250 | 50.7% |
| 92250 | Photography of the retina | Office | 2023 | 383 | 394 | $22,512 | $10,804 | 48.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 108 | 108 | $24,501 | $10,485 | 42.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 121 | 144 | $13,711 | $6,612 | 48.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 12 | 12 | $6,153 | $3,291 | 53.5% |
| 92134 | Imaging of retina | Office | 2023 | 77 | 88 | $5,428 | $2,570 | 47.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 49 | 67 | $4,807 | $2,191 | 45.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 56 | 62 | $3,482 | $1,682 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $3,566 | $1,575 | 44.2% |
| 92285 | Photography of content of eyes | Office | 2023 | 46 | 49 | $1,753 | $815.27 | 46.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 376 | 383 | $74,658 | $35,844 | 48.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 45 | 69 | $58,130 | $30,443 | 52.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 266 | 391 | $53,911 | $26,506 | 49.2% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 158 | 158 | $36,380 | $16,935 | 46.5% |
| 92250 | Photography of the retina | Office | 2022 | 377 | 384 | $22,084 | $10,690 | 48.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 160 | 188 | $18,140 | $8,940 | 49.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 15 | 19 | $9,834 | $4,859 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 47 | $9,405 | $4,449 | 47.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 55 | 79 | $6,062 | $3,111 | 51.3% |
| 92134 | Imaging of retina | Office | 2022 | 69 | 80 | $5,016 | $2,535 | 50.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 75 | 83 | $4,730 | $2,257 | 47.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $4,508 | $1,925 | 42.7% |
| 92285 | Photography of content of eyes | Office | 2022 | 53 | 57 | $2,065 | $948.42 | 45.9% |
About Dr. Edgar Caceres, MD
Dr. Edgar Caceres, MD is a Ophthalmology healthcare provider based in Palm Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679547236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edgar Caceres, MD has received a total of $874.64 in payments from pharmaceutical and medical device companies, with $216.27 received in 2024. These payments were reported across 44 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($874.64).
As a Medicare-enrolled provider, Caceres has provided services to 6,719 Medicare beneficiaries, totaling 7,692 services with total Medicare billing of $589,184. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Palm Springs, FL
- Active Since 02/13/2006
- Last Updated 10/05/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679547236
Products in Payments
- Cequa (Drug) $156.90
- TRAVATAN Z (Drug) $109.03
- XIIDRA (Drug) $88.79
- LUMIGAN (Drug) $79.52
- Clareon (Device) $67.16
- CEQUA (Drug) $64.00
- XDEMVY (Drug) $46.17
- Omidria (Drug) $44.25
- TYRVAYA (Drug) $34.89
- DURYSTA (Drug) $26.97
- MIEBO (Drug) $22.63
- TEPEZZA (Biological) $22.29
- INVELTYS (Drug) $21.44
- VYZULTA (Drug) $20.45
- IYUZEH (Drug) $20.19
- VEVYE (Drug) $14.78
- Flarex (Drug) $12.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Palm Springs
Dr. Wallace Goldban, M.d, M.D
Ophthalmology — Payments: $42,904
Dr. Daniel Goldberg, M.d, M.D
Ophthalmology — Payments: $6,207
Dr. Tommy Coffman, Md, MD
Ophthalmology — Payments: $4,092
Dr. Virginia Klair, M.d, M.D
Ophthalmology — Payments: $2,103
William Martin, Md, MD
Ophthalmology — Payments: $1,486
Robert Guss, Md, MD
Ophthalmology — Payments: $1,445